We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shield Therapeutics Plc | LSE:STX | London | Ordinary Share | GB00BYV81293 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.15 | 7.50% | 2.15 | 2.10 | 2.20 | 2.15 | 2.00 | 2.00 | 2,572,354 | 10:18:35 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 4.47M | -40.44M | -0.0522 | -0.41 | 16.67M |
Date | Subject | Author | Discuss |
---|---|---|---|
29/6/2021 12:26 | If a product is proven and has distinct advantages over the competitor product as Accrufer does, then its just a question of employing a sufficient number of incentivised competent salesmen and the product will sell. The new CEO seems to know what he is doing and understands the market, should be a cake walk for him, there are no complex problems or difficult hurdles to overcome. | rogerrail | |
29/6/2021 12:09 | Love words like 'huge growth' :) | zeus19 | |
29/6/2021 12:07 | Thanks dent, wouldn`t be surprised to see an update from funky finance soon either. | dandu69 | |
29/6/2021 11:40 | hxxps://www.business | dent12 | |
29/6/2021 10:49 | Sorry wrong way round buys as sells. Ooops | little minx | |
29/6/2021 10:45 | As already discussed algorithms shows sells as buy so giving a nice distorted image. | little minx | |
29/6/2021 09:47 | Yes, and then it might rise up to 50p !!! | daveboy19 | |
29/6/2021 09:33 | With a bit of luck at the end of September we might get a quarterly update on the first sales!!.. | cyberbub | |
28/6/2021 19:00 | A FUNKY SHARE... just keep buying the dips and hold for 10 yrs | transhoneyqueens | |
28/6/2021 17:23 | Friskymickey....the way I look at it is very simple. Except for those with intolerance or other reasons that they cannot take Accrufer, all the patients with IDS will have a choice. Spend more and all the time, discomfort etc and have IV or take Accrufer. Now I really hate the expression...it's a no brainer....but sometimes it is relevant. OK there will be some months of uncertainty but I look at the logic always. What would you do in this decision process given you MUST have one. Buy. Hold. Forget. Wake up in two years and go nice. | purchaseatthetop | |
28/6/2021 15:47 | Thanks PATT, with product on sale from Thursday and i liked the spread so could not resist. | friskymickey | |
28/6/2021 15:40 | Forget about the price UNLESS you do a great value add like friskymickey...good call | purchaseatthetop | |
28/6/2021 15:16 | Just topped up at 52.38p :) | friskymickey | |
28/6/2021 10:42 | Just forget about the share price for the next months. Makes no difference to the price in three years. If Greg delivers which I am sure he will it might be around 250p. What it does now is determined by nervous Nigel from Bermondsey who wants to buy EEE cos Twitter tells him to so sells STX because he cannot miss out. | purchaseatthetop | |
28/6/2021 10:37 | Yes the share price is being very controlled imho | little minx | |
28/6/2021 10:31 | Dropping it on very low volume again. Same as last week. | eastlands | |
28/6/2021 10:21 | So you know the exact plan of the new CEO inside out?Then please enlighten us with your inside knowledge. | little minx | |
28/6/2021 10:20 | So you know the new | little minx | |
28/6/2021 10:12 | Kodak made billions selling their rolls of film invented by Eastman In 1975 one of their employees invented the digital camara. They sat on the patent for years and did nothing because they worried that it would undermine their film business,eventually a competitor started selling digital cameras Kodak licensed the patents out and did nothing .In three years they went bust We see the benefit to the patients of the pill over the infusion but the existing players, they only see this as a threat to their infusion business. Our marketing people are going to get absolutely nowhere by approaching big infusion providers. They need to think just a little outside of the box. My Nickname is very appropriate .I am a disrupter not a follower. There is a way to make billions from our iron deficiency treatment but it’s not this way. | baddogrex1 | |
25/6/2021 20:47 | PerformanceThe Group closed 2020 with £2.9 million cash but has since raised £29.2 million gross proceeds from a fundraise completed in March 2021. | oapknob1 | |
25/6/2021 20:42 | Why you reckon they've spent this since 26th February 2021 then.Shield Therapeutics PLC Successful completion of GBP25 million Fundraise | oapknob1 | |
25/6/2021 19:04 | maybe we will need additional funding next month ? | jackson83 | |
25/6/2021 17:18 | Friskymickey...not really. We have our logic but do not see how many are wanting to sell with the news. Delighted with this week. 60p will come sooner rather than later and then be left in the dust. Even those who bought on the news at 58p and got spiked will be fine soon. It is the way it is. | purchaseatthetop | |
25/6/2021 15:52 | 60p by end of the week lmao ramp ramp ramp.... | friskymickey |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions